Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response

Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response

Introduction: Belatacept is a common immunosuppressive therapy used after kidney transplantation (KT) to avoid calcineurin-inhibitor (CNI) use and its related toxicities. It is unclear whether its use exposes KT recipients (KTx) to a greater risk of infection or a poorer response to vaccines. Areas...

Full description

Bibliographic Details
Main Authors: Florian Terrec, Thomas Jouve, Paolo Malvezzi, Bénédicte Janbon, Hamza Naciri Bennani, Lionel Rostaing, Johan Noble
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Journal of Clinical Medicine
Subjects:
kidney transplantation
immunosuppressive regimen
opportunistic infections
belatacept
cytomegalovirus
CD80/CD86
Online Access:https://www.mdpi.com/2077-0383/10/21/5159

Similar Items

Similar Items